SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001009448-09-000052
Filing Date
2009-07-02
Accepted
2009-07-02 14:53:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOTEX SCHEDULE 13G schedule13g012009.htm SC 13G 88301
  Complete submission text file 0001009448-09-000052.txt   90250
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 09926775
SIC: 2834 Pharmaceutical Preparations

Mailing Address 220 WEST 42ND STREET 6TH FLOOR NEW YORK NY 10036
Business Address 212-763-5550
Biotex Pharma Investments, LLC (Filed by) CIK: 0001467543 (see all company filings)

IRS No.: 264195350
Type: SC 13G